Business Name: |
Ektek LLC |
Contact Person: |
Gregory Kellogg |
Address: |
131 Magazine St, Cambridge, Massachusetts 02139 |
Phone Number: |
(781) 799-4792 |
Annual Revenue (USD): |
$50.000 to $99.999 |
Founding Year: |
2012 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2B (Business to Business) |
Business Category: |
Research and Development Laboratories |
SIC Code: |
8731 |
NAICS Code: |
541712 |
Share This Business: |
|
Related Businesses: |
Ambri Inc - Cambridge, MA 02139 Sunpoint Technologies Inc - Cambridge, MA 02139 Aramark - Cambridge, MA 02139 Twin Lights Bioscience Inc - Cambridge, MA 02139 Good Start Genetics Inc - Cambridge, MA 02139 Hybrid Silica Technologies Inc - Cambridge, MA 02139 Unison Technologies LLC - Cambridge, MA 02139 H3 Biomedicine Inc - Cambridge, MA 02139 Gemedy Inc - Cambridge, MA 02139 Axios Biosciences LLC - Cambridge, MA 02139 Seaside Therapeutics LLC - Cambridge, MA 02139 Epieye Technologies - Cambridge, MA 02139 Realtime Technologies Limited - Cambridge, MA 02139 Srinivas Tejaswinhi - Cambridge, MA 02139 Simba Medical LLC - Cambridge, MA 02139 Axia Systems Technology Inc - Cambridge, MA 02139 Q-State Biosciences Inc - Cambridge, MA 02139 Oravax Inc - Cambridge, MA 02139 One Cell - Cambridge, MA 02139 Archemix Corp - Cambridge, MA 02139 |
The company Ektek LLC provides B2B services in the form of Research and Development Laboratories from its single location in Massachusetts.
1 to 4 employees work for Ektek LLC, and the business now earns $50.000 to $99.999 per annum.
Ektek LLC was launched in 2012 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 .
To contact Ektek LLC, please call Gregory Kellogg with the phone number (781) 799-4792 or visit its single location at 131 Magazine St in Cambridge, Massachusetts 02139.
The location of the single location can also be found using the coordinates 42.359,-71.111429.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.